Ecto-5'-nucleotidase (CD73), the ectoenzyme that together with CD39 is responsible for extracellular ATP hydrolysis and adenosine accumulation, regulates immune/inflammatory processes by controlling innate and acquired immunity cell functions. We previously demonstrated that CD73 is required for the assessment of a controlled allergic sensitization, in mice. Here, we evaluated the response to aerosolized allergen of female-sensitized mice lacking CD73 in comparison with their wild type counterpart. Results obtained show, in mice lacking CD73, the absence of airway hyperreactivity in response to an allergen challenge, paralleled by reduced airway CD23+B cells and IL4+T cells pulmonary accumulation together with reduced mast cells accumulation and degranulation. Our findings indicate CD73 as a potential therapeutic target for allergic asthma.
Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge / Caiazzo, Elisabetta; Cerqua, Ida; Turiello, Roberta; Riemma, Maria Antonietta; De Palma, Giacomo; Ialenti, Armando; Roviezzo, Fiorentina; Morello, Silvana; Cicala, Carla. - In: BIOMOLECULES. - ISSN 2218-273X. - 12:5(2022), p. 697. [10.3390/biom12050697]
Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge
Caiazzo, ElisabettaPrimo
;Cerqua, Ida;Riemma, Maria Antonietta;De Palma, Giacomo;Ialenti, Armando;Roviezzo, Fiorentina;Cicala, Carla
2022
Abstract
Ecto-5'-nucleotidase (CD73), the ectoenzyme that together with CD39 is responsible for extracellular ATP hydrolysis and adenosine accumulation, regulates immune/inflammatory processes by controlling innate and acquired immunity cell functions. We previously demonstrated that CD73 is required for the assessment of a controlled allergic sensitization, in mice. Here, we evaluated the response to aerosolized allergen of female-sensitized mice lacking CD73 in comparison with their wild type counterpart. Results obtained show, in mice lacking CD73, the absence of airway hyperreactivity in response to an allergen challenge, paralleled by reduced airway CD23+B cells and IL4+T cells pulmonary accumulation together with reduced mast cells accumulation and degranulation. Our findings indicate CD73 as a potential therapeutic target for allergic asthma.File | Dimensione | Formato | |
---|---|---|---|
biomolecules-12-00697.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
2.32 MB
Formato
Adobe PDF
|
2.32 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.